Agree Realty is an integrated real estate investment trust primarily focused on the ownership, acquisition, development and management of retail properties net leased to tenants. The company's assets are held by, and all of its operations are conducted through, directly or indirectly, Agree Limited Partnership, of which the company is the sole general partner and in which it holds a majority interest.

Argan is a holding company. The company conducts operations through its subsidiaries: Gemma Power Systems, LLC, which is an engineering, procurement and construction contractor; Atlantic Projects Company Limited, which provides turbine, boiler and rotating equipment installation, commissioning and outage services; The Roberts Company, Inc., which provides on-site services that support maintenance, shutdowns and emergency mobilizations for industrial plants in the southern region of the U.S.; and Southern Maryland Cable, Inc., which conducts business as SMC Infrastructure Solutions, and provides technology wiring and utility construction solutions to customers in the mid-Atlantic region of the U.S.

Avid Biosciences is a contract development and manufacturing organization that provides a range of services from process development to Current Good Manufacturing Practices (CGMP) commercial manufacturing focused on biopharmaceutical products derived from mammalian cell culture. The company's services include CGMP clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company also provides a variety of process development services, including cell line development and optimization, cell culture and feed optimization, analytical methods development and product characterization.

Bridgewater Bancshares is a financial holding company. Through its subsidiaries, Bridgewater Bank (the Bank) and Bridgewater Risk Management, Inc., the company provides a range of loan and deposit products primarily for commercial clients. Additionally, the company provides support and personalized solutions tailored for each client. The Bank focuses primarily on commercial lending as well as commercial real estate loans that consist of owner and non-owner occupied properties. In addition, the Bank is engaged in construction lending, which includes single family residential construction loans, land development, finished lots and raw land loans, and commercial and multifamily construction.

Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization of biological therapies for the treatment of diseases, with a focus on Duchenne muscular dystrophy (DMD), and other rare disorders. The company's drug candidates in active development consist of: CAP-1002 (allogeneic cardiosphere-derived cells (CDCs)), which is for the treatment of DMD, advanced heart failure and myocardial infarction; and CAP-2003 (CDC extracellular vesicles, including exosomes), which is for the treatment of inflammatory conditions. CAP-2003 is in pre-clinical development.

Champions Oncology is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The company's TumorGraft Technology Platform is an approach to personalizing cancer care. The company provides solutions for two consumer groups: Translational Oncology Solutions, which provides a technology platform to pharmaceutical and biotechnology companies using proprietary TumorGraft studies; and Personalized Oncology Solutions, which assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services.

Citi Trends is a retailer of fashion apparel and accessories for the entire family. The company also provides a variety of products from less recognized brands and a lesser amount representing private label products under its brands. The company's merchandise includes apparel, accessories and home. Within apparel, the company provides fashion sportswear for men, women and children, including offerings for newborns, infants, toddlers, boys and girls. Accessories include handbags, jewelry, footwear, belts, intimate apparel, scrubs and sleepwear. Home includes functional bedroom, bathroom and kitchen products, as well as beauty and toys.

Coty and its subsidiaries are a beauty company. The company manufactures, markets, sells and distributes beauty products, including fragrances, color cosmetics, hair care products and skin and body related products. The company is organized into three divisions, which is also its operating and reportable segments: Consumer Beauty, Luxury and Professional Beauty. Consumer Beauty is primarily focused on color cosmetics, retail hair coloring and styling products, body care and mass fragrances. Luxury is primarily focused on fragrances, skincare and cosmetics. Professional Beauty is primarily focused on hair and nail care products for salon personnel.

Cracker Barrel Old Country Store is principally engaged in the operation and development of the Cracker Barrel Old Country Store? concept. The format of the company's stores consists of a trademarked rustic old country-store design providing a restaurant menu that features home-style country food and a variety of items such as rocking chairs, holiday and seasonal gifts, toys, apparel, cookware and foods. The company's restaurants serve breakfast, lunch and dinner daily. Lunch and dinner items include southern fried chicken, chicken and dumplings, chicken fried chicken, meatloaf, country fried steak, pork chops, fish, steak, roast beef, vegetable plates, sandwiches and a variety of salads.

DocuSign provides e-signature solution as the main part of its cloud software suite for automating the agreement process. The company calls its suite the DocuSign Agreement Cloud. The DocuSign Agreement Cloud is designed to allow companies of various sizes and across various industries to make agreement, approval process, or transaction digital, from practically any device, from almost anywhere in the world.

Dollar General is a discount retailer. The company's consumables products includes paper and cleaning products, packaged food, perishables, snacks, health and beauty, pet, and tobacco products. The company's seasonal products include decorations, toys, batteries, small electronics, greeting cards, stationery, prepaid phones and accessories, gardening supplies, hardware, automotive and home office supplies. The company's home products include kitchen supplies, cookware, small appliances, light bulbs, storage containers, frames, candles, craft supplies and kitchen, bed and bath soft goods. The company's apparel includes casual everyday apparel, as well as socks, underwear, disposable diapers, shoes and accessories.

Spirit Bear Capital is a capital pool company. The principal business of Co. is the identification and evaluation of assets or a business and, once identified or evaluated, to negotiate an acquisition or participation in a business subject to receipt of shareholder approval, if required, and acceptance by regulatory authorities.

Genasys is a provider of communications solutions. The company's platform provides a multi-channel approach to deliver alerts, notifications, instructions and information before, during and after public safety threats, and critical events. The company's multi-channel approach includes: Long Range Acoustic Devices that project sirens and audible voice messages with exceptional vocal clarity; Critical Communications as a Service software that is a solution for sending SMS, text, email and social media messages to mobile devices in defined geographic areas, and; Integrated Solutions that span multiple hardware and software mobile notification channels so that information can be delivered to people.

Ligand Pharmaceuticals is a biopharmaceutical company focused on developing and acquiring technologies that help pharmaceutical companies discover and develop medicines. The company employs research technologies such as antibody discovery technologies, structure-based drug design, formulation science and liver targeted pro-drug technologies to assist companies in their work toward securing prescription drug and biologic approvals. The company's collaboration partners and licensees have programs in clinical development targeting cancer, seizure, diabetes, cardiovascular disease, muscle wasting, liver disease, and kidney disease, among others.

Methode Electronics is a manufacturer of component and subsystem devices. The company's business segments are: Automotive, which supplies electronic and electro-mechanical devices and related products; Industrial, which manufactures external lighting solutions, industrial safety radio remote controls, braided flexible cables, current-carrying laminated busbars and devices; Interface, which provides a variety of copper and fiber-optic interface and interface solutions for the appliance, commercial food service, construction, consumer, material handling, point-of-sale and telecommunications markets; and Medical, which includes surface support technology aimed at pressure injury prevention.

Motorcar Parts of America is a supplier of automotive aftermarket non-discretionary replacement parts and diagnostic equipment. The company's non-discretionary replacement parts are sold to automotive retail chain stores and warehouse distributors throughout North America and to main automobile manufacturers for both their aftermarket programs and warranty replacement programs. The company's hard parts portfolio includes: rotating electrical products such as alternators and starters, wheel hub assemblies and bearings, and brake master cylinders. The company's diagnostic equipment portfolio includes: bench top alternator and starter testing, production alternator and starter, and alternator and starter endurance.

NIKE is engaged in the design, development and marketing and selling of athletic footwear, apparel, equipment, accessories and services. The company focuses its NIKE Brand product offerings in Running, NIKE Basketball, the Jordan Brand, Football (Soccer), Training and Sportswear categories. The company markets products designed for kids, as well as for other athletic and recreational uses such as American football, baseball, cricket, golf, lacrosse, tennis, walking, and other outdoor activities. The company has license agreements that permit unaffiliated parties to manufacture and sell, using the company-owned trademarks, certain apparel, digital devices and applications and other equipment designed for sports activities.

Perma-Fix Environmental Services, through its subsidiaries, is an environmental and environmental technology company. The company has three segments: Treatment, which includes nuclear, low-level radioactive, mixed waste, hazardous and non-hazardous waste treatment, processing and disposal services, as well as research and development activities to identify, develop and implement waste processing techniques for problematic waste streams; Services, which includes on-site waste management services to commercial and governmental customers, and an equipment calibration and maintenance laboratory; and Medical, which includes research and development of the company's medical isotope production technology.

Soleno Therapeutics is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company's primary candidate, Diazoxide Choline Controlled Release (DCCR) tablets, a once-daily oral tablet for the treatment of Prader-Willi Syndrome (PWS), is being evaluated in a Phase III clinical development program. The company's research and development efforts are primarily focused on developing its primary candidate, DCCR tablets for the treatment of PWS, through late-stage clinical development.

Vaccinex is a clinical-stage biotechnology company engaged in the discovery and development of targeted biotherapeutics to treat diseases and conditions, including cancer, neurodegenerative diseases, and autoimmune disorders. The company is engaged in the field of semaphorin 4D (SEMA4D) biology, targeting SEMA4D as a potential treatment for cancer, neurodegenerative diseases, or autoimmune disorders. The company is utilizing its SEMA4D antibody platform to develop its primary product candidate, pepinemab (VX15/2503), an antibody that utilizes mechanisms of action. The company is focused on the development of pepinemab for the treatment of non-small cell lung cancer, Huntington's disease, and Alzheimer's disease.